Clinical Trials Archives

Aptose Biosciences Announces Public Offering and Strategic Investment

Post author:auditor
Post published:January 26, 2024
Post category:News
Post comments:0 Comments
Post last modified:January 26, 2024

Aptose Biosciences, a renowned biopharmaceutical company, recently announced its plans for a public offering and a strategic investment. Unfortunately, this news has caused a temporary decline in the company's shares.…

FDA Rejects Outlook Therapeutics’ Proposed Treatment for Wet AMD

Post author:auditor
Post published:August 30, 2023
Post category:News
Post comments:0 Comments
Post last modified:August 30, 2023

Outlook Therapeutics faced a major setback on Wednesday as the U.S. Food and Drug Administration (FDA) rejected its proposed treatment for wet age-related macular degeneration (AMD). The biopharmaceutical company's shares…

Aptose Biosciences Announces Public Offering and Strategic Investment

FDA Rejects Outlook Therapeutics’ Proposed Treatment for Wet AMD

Reviews

Markets

Education

Company